Resistance from antagonistic muscle groups might be a crucial factor reducing function in chronic hemiparesis. The resistance due to spastic co-contraction might be reduced by botulinum toxin injections. We assessed the effects of abobotulinumtoxinA injection in the upper limb muscles on muscle tone, spasticity, active movement, and function.
Gracies, J., Brashear, A., Jech, R., Mcallister, P., Banach, M., Valkovic, P., Walker, H., Marciniak, C., Deltombe, T., Skoromets, A., Khatkova, S., Edgley, S., Gul, F., Catus, F., De Fer, B., Vilain, C., Picaut, P., Ayyoub, Z., Banach, M., Bensmail, D., Bentivoglio, A. R., Boyer, F., Brashear, A., Csanyi, A., Deltombe, T., Denes, Z., Edgley, S., Gul, F., Gracies, J., Hedera, P., Isaacson, S., Isner Horobeti, M., Jech, R., Kaminska, A., Khatkova, S., Kocer, S., Lejeune, T., Mcallister, P., Marciniak, C., Marque, P., O'dell, M., Remy Neris, O., Rubin, B., Rudzinska, M., Simpson, D., Skoromets, A., Timerbaeva, S., Valkovic, P., Vecchio, M., Walker, H., Wimmer, M., Safety and efficacy of abobotulinumtoxinA for hemiparesis in adults with upper limb spasticity after stroke or traumatic brain injury: a double-blind randomised controlled trial, <<THE LANCET>>, 2015; 14 (10): 992-1001. [doi:10.1016/S1474-4422(15)00216-1] [http://hdl.handle.net/10807/69797]
Autori: | |
Titolo: | Safety and efficacy of abobotulinumtoxinA for hemiparesis in adults with upper limb spasticity after stroke or traumatic brain injury: a double-blind randomised controlled trial |
Digital Object Identifier (DOI): | http://dx.doi.org/10.1016/S1474-4422(15)00216-1 |
Data di pubblicazione: | 2015 |
Abstract: | Resistance from antagonistic muscle groups might be a crucial factor reducing function in chronic hemiparesis. The resistance due to spastic co-contraction might be reduced by botulinum toxin injections. We assessed the effects of abobotulinumtoxinA injection in the upper limb muscles on muscle tone, spasticity, active movement, and function. |
Lingua: | Inglese |
Rivista: | |
Citazione: | Gracies, J., Brashear, A., Jech, R., Mcallister, P., Banach, M., Valkovic, P., Walker, H., Marciniak, C., Deltombe, T., Skoromets, A., Khatkova, S., Edgley, S., Gul, F., Catus, F., De Fer, B., Vilain, C., Picaut, P., Ayyoub, Z., Banach, M., Bensmail, D., Bentivoglio, A. R., Boyer, F., Brashear, A., Csanyi, A., Deltombe, T., Denes, Z., Edgley, S., Gul, F., Gracies, J., Hedera, P., Isaacson, S., Isner Horobeti, M., Jech, R., Kaminska, A., Khatkova, S., Kocer, S., Lejeune, T., Mcallister, P., Marciniak, C., Marque, P., O'dell, M., Remy Neris, O., Rubin, B., Rudzinska, M., Simpson, D., Skoromets, A., Timerbaeva, S., Valkovic, P., Vecchio, M., Walker, H., Wimmer, M., Safety and efficacy of abobotulinumtoxinA for hemiparesis in adults with upper limb spasticity after stroke or traumatic brain injury: a double-blind randomised controlled trial, <<THE LANCET>>, 2015; 14 (10): 992-1001. [doi:10.1016/S1474-4422(15)00216-1] [http://hdl.handle.net/10807/69797] |
Appare nelle tipologie: | Articolo in rivista, Nota a sentenza |